International (WHO Member States)

WHO Global Model Regulatory Framework for Medical Devices including In Vitro Diagnostic Medical Devices

56 controls. 0 other frameworks in our corpus share controls with it. Here is all of it, and how much of it you are already doing.

Page built . This page is derived from the framework corpus, which changes when the corpus is extended rather than daily.

56 controls 0 frameworks share controls with it International (WHO Member States) verified against its source document

Every control below is one this framework asks for. The right hand column counts how many other frameworks in our corpus carry the same control, which is the difference between doing this work once and doing it again for the next standard.

There is no implementation kit for this framework yet. The control list and the overlap above are free and complete.

What you already have

Frameworks whose controls overlap this one, most first. If you run any of them, the count is roughly what you have already evidenced.

No measured overlap with another framework in the corpus.

Every control

CodeControlAlso in
4.2-classifyManufacturers classify each device and IVD by the harmonized risk-based rules, applying the higher class where two could apply, and accept that the NRA may review or overturn the c0
4.3-EPShow that every device conforms to the applicable essential principles of safety and performance throughout its life cycle, preferably by applying recognised international standard0
4.3-changesKeep changes to intended purpose, design, specifications, labelling or manufacture in conformity with the essential principles, classify changes as substantial or not under a proce0
4.3.1-clinicalCompile clinical evidence and a documented clinical evaluation under the QMS as part of the technical documentation, with new data for novel high-risk devices and investigations to0
4.4.3-IVDFor IVDs, establish clinical evidence covering scientific validity, analytical performance and clinical performance, with performance studies on human specimens to ISO 209160
4.4.4-lotSupport NRA-required lot verification testing of high-risk (Class D) IVDs and control transport and storage so lot performance is not affected0
5.1-lawGovernment: give device regulation a sound legal basis that defines products and regulated parties, requires only safe, performing, quality devices on the market, empowers and hold0
5.2-5.4-planGovernment and NRA: carry out a gap analysis with stakeholders, publish a risk-based implementation plan aligned with resources, and monitor implementation with indicators (such as0
5.5-5.7-NRAGovernment: appoint an NRA with independent decision-making, defined governance and public performance reporting, adequate and transparent funding (fair, reviewed user fees if any)0
5.8-9.3-capacityNRA: build and maintain regulatory competence through recruitment, retention, formal selection and annual training plans, evidence of staff competence, expert committees and extern0
5.9-relianceGovernment and NRA: provide in law for reliance on and recognition of reference regulators, CABs and WHO, keep national-only functions in-country, and join information-sharing netw0
6.1-stepwiseNRA: implement controls stepwise, enforcing the basic-level controls before adopting expanded-level ones, and only when the legal basis and resources exist0
6.2.1.1-6.2.1.2-NRANRA: adopt a harmonized risk classification scheme with guidance and a voluntary classification consultation, require declarations of conformity with the essential principles, and 0
6.2.2.2-DoCDraw up, hold and supply on request a signed declaration of conformity for each device with the minimum content, and keep the supporting technical documentation available for verif0
6.2.2.3-QMSEstablish and maintain, for every device class, a QMS with records suited to the processes and products, aligned with ISO 13485 and ISO 14971 at their latest editions0
6.2.2.4-labellingProvide labels and instructions suited to the intended user and in an accepted language, with intended purpose, contraindications, warnings, identification for traceability, UDI wh0
6.2.2.5-advertisingAdvertise and promote devices only within their authorized intended purpose, with evidence-backed claims, to appropriate audiences, and never falsely, misleadingly or deceptively0
6.2.2.6-exceptionsGovernment and NRA: define exemptions and enforcement discretion for emergencies, humanitarian use, individual patients, clinical investigations, exhibitions and donations, with ri0
6.2.3-ARA manufacturer outside the jurisdiction appoints a local authorized representative, under an agreement setting out who meets each national requirement and keeps distribution record0
6.2.3-NRA-registersNRA: run establishment registration and device listing systems, check them periodically, publish them, and specify listing data and nomenclature0
6.2.3.1-registrationRegister each local manufacturer, authorized representative, importer and distributor establishment with the NRA, with a separate registration for each role, and notify significant0
6.2.3.1.1-AR-dutiesAs authorized representative, give the NRA business and contact details, list devices and keep the list current, support authorization applications, relay feedback and FSCA, cooper0
6.2.3.1.2-importerImporters and distributors register, supply only conforming devices with proper labelling and instructions, pass feedback and complaints to the manufacturer or representative, keep0
6.2.3.2-listingSubmit and keep current a listing of each device placed on the national market, using an internationally recognised nomenclature and information consistent with the technical docum0
6.2.3.3-NRA-importNRA: decide which device categories need extra import controls, train customs, designate ports of entry, and hold powers to stop non-compliant imports0
6.2.3.3-importSupply the import documentation the NRA requires (QMS certificates, proof of authorization in the exporting country, declaration of conformity, test reports), import through design0
6.2.4-NRA-vigilanceNRA: run a reporting system for adverse events from manufacturers, users and patients, forward reports for investigation, assess risks, exchange information with other NRAs, issue 0
6.2.4.1-AEReport to the NRA serious public health threats, deaths or serious deteriorations in health, and failures or design, labelling or use problems that could cause them, plus any false0
6.2.4.2-FSCANotify the NRA promptly of every field safety corrective action undertaken in the country, issue field safety notices, and allow the NRA to monitor the effectiveness of corrective 0
6.2.4.3-NRA-enforceNRA: enforce against non-compliant, unsafe or falsified devices with proportionate measures, consult manufacturers before public alerts, inform the public and share concerns with t0
6.2.4.3-withdrawalCooperate with NRA enforcement against unsafe or non-compliant devices, including withdrawal, quarantine and disposal, and review technical documentation and revise labelling when 0
6.2.4.5-6.3.3.2-MSNRA: conduct risk-based market surveillance using distribution-chain risk, user feedback and manufacturer surveillance data, with focused sampling and testing through collaborating0
6.3.1-NRA-premarketNRA: oversee clinical investigations, recognise and supervise CABs, adopt a nomenclature system and a UDI system aligned with international practice, and control advertising0
6.3.1.1-CISponsors obtain prior NRA authorization for new clinical investigations, run them under ethics committee oversight with informed consent to ISO 14155, and report progress and serio0
6.3.1.5-UDIWhere the NRA adopts UDI, assign UDI-DIs and UDI-PIs through an accredited issuing agency, apply them to labels and packaging in human- and machine-readable form, and submit UDI-DI0
6.3.2-NRA-reviewNRA: verify manufacturers' QMS by audit or reliance on valid certificates, review submissions against transparent criteria using harmonized formats, apply extended review triggers,0
6.3.3.1-PMSOperate post-market surveillance within the QMS that collects user feedback, reviews the benefit-risk profile, reports the required events, evaluates and takes corrective action, w0
6.3.3.3-NRA-inspectNRA: inspect registered establishments on a risk basis (scheduled or unannounced), rely on trusted inspections where possible, and license, suspend or withdraw registrations for un0
6.3.3.3.1-distributionManufacturers select and contract qualified distributors and specify storage, handling, transport, installation, servicing, traceability and disposal requirements; distributors run0
6.3.3.4-localGovernment and NRA: support quality local production with good regulatory practice, apply the same controls to local and imported devices, offer pre-submission meetings and imparti0
6.3.3.5-testingNRA: avoid routine testing, use accredited laboratories (ISO/IEC 17025, ISO 15189) under defined agreements or reliance for targeted testing of falsified, incident-related, priorit0
7.3-7.6-NRA-pathwaysNRA: establish emergency use authorization criteria and validity limits, borderline product and combination product designation processes with published decisions and appeal, and a0
7.3-EUAApplicants for emergency use authorization submit the evidence available, keep seeking and submitting new evidence, monitor post-market safety and performance, and move to full ass0
7.5-combinationFor medicine-device combination products, follow the designated regulatory pathway (by primary mode of action), meet the GMP or QMS, verification and post-market requirements set f0
7.6-donationsDonors ensure donated devices meet the receiving country's requirements, respond to an expressed clinical need, are complete, documented in a local language, suited to local condit0
8.1-disposalGive users decontamination and disposal instructions, and dispose of devices at end of life (or earlier if hazardous) safely in line with manufacturer recommendations and local rul0
8.2-8.4-NRA-policyNRA: set policy on reprocessing single-use devices and refurbishing, and build oversight of SaMD and machine learning devices, including local dataset representativeness, update an0
8.2-reprocessingDo not reuse single-use devices except under NRA-permitted conditions; an entity reprocessing them becomes the manufacturer, with risk assessment, validated reprocessing, a QMS, tr0
8.3-refurbishingRefurbishers meet the same requirements as original manufacturers (QMS certificate, technical documentation, declaration of conformity) and identify refurbished devices as such on 0
8.4-SaMDFor SaMD and software in devices, including machine learning devices, demonstrate scientific validity, analytical validity and clinical performance, run life-cycle processes under 0
8.5-SFReport suspected substandard or falsified devices to the NRA, buy and distribute only through reliable sources, and use UDI and track-and-trace tools to protect supply chain integr0
8.6-CDxFor companion diagnostics, obtain authorization for clinical performance studies and market entry, label the corresponding medicine where the test is tied to it, and report test fa0
8.7-8.9-WHOWHO prequalification, the collaborative registration procedure and emergency use listing0
9.1-stakeholdersGovernment and NRA: involve stakeholders throughout the regulatory process and assess the public health, economic and social impact of proposed controls0
purposePurpose, audience and structure of the GMRF0
terms-definitionsTerminology and the harmonized definitions of medical device and IVD0

Tell me when WHO Global Model Regulatory Framework for Medical Devices including In Vitro Diagnostic Medical Devices files something new

One email when a public company newly discloses something this framework governs, naming the company and what our corpus says it puts in scope. Nothing else, and one click to stop.

What this page is

A control-level reference for WHO Global Model Regulatory Framework for Medical Devices including In Vitro Diagnostic Medical Devices, drawn from our framework corpus. Control codes and titles are references to the standard, not reproductions of it. The overlap counts and the auditor artefacts are our own work and are the part you will not find elsewhere.

Measure this against what you already run · All frameworks · Today's edition